Dopamine

dopa decarboxylase ; Homo sapiens







171 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 16829205 Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. 2006 Oct 2
102 17135716 Co-expression of tyrosine hydroxylase and GTP cyclohydrolase I in arginine vasopressin-synthesizing neurons of the human supraoptic nucleus demonstrated by laser microdissection and real-time PCR. 2006 1
103 15821966 Visualisation of impaired dopamine biosynthesis in a case of aromatic L-amino acid decarboxylase deficiency by co-registered 18F-FDOPA PET and magnetic resonance imaging. 2005 Apr 1
104 15836622 Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity. 2005 May 1
105 15879433 Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. 2005 Jun 15 3
106 15900211 The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. 2005 Jun 1
107 16447758 [Gene therapy and cell transplantation for Parkinson's disease]. 2005 Nov 1
108 14760382 Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. 2004 Feb 9 2
109 15191803 The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. 2004 Jul 2
110 15318031 No association between polymorphisms in the DDC gene and paranoid schizophrenia in a northern Chinese population. 2004 Sep 2
111 15500713 [Gene therapy of tyrosine hydroxylase, aromatic L-amino acid decarboxylase, and GTP cyclohydrolase genes in rat model of Parkinson's disease]. 2004 Sep 17 1
112 20641732 4-[18F]Fluoro-l-m-tyrosine 2004 1
113 12555230 Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder. 2003 Feb 1
114 12718431 Cloning and expression of human placental L-Dopa decarboxylase. 2003 Jun 2
115 12808505 [Ex vivo gene therapy in the treatment of Parkinson s disease]. 2003 Jun 1-15 1
116 12938190 HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro. 2003 Oct 2
117 14566408 [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro]. 2003 Oct 25 3
118 15152479 [AAV vector-mediated gene transfer and its application to the nervous system]. 2003 Nov 4
119 11860702 Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. 2002 Feb 10 2
120 11889758 [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients]. 2002 Feb 1
121 12084631 Is DOPA a neurotransmitter? 2002 Jun 1
122 12116187 Association study between two variants in the DOPA decarboxylase gene in bipolar and unipolar affective disorder. 2002 Jul 8 3
123 12200739 Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. 2002 Jun 5
124 11148450 Identification of the aromatic L-amino acid decarboxylase (AADC) gene and its expression in the attachment and metamorphosis of the barnacle, Balanus amphitrite. 2001 Feb 1
125 11443526 Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population. 2001 Jul 2
126 11532645 Parkinson's disease: medical and surgical treatment. 2001 Aug 1
127 11592835 Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats. 2001 Oct 1
128 11685243 Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase. 2001 Nov 2
129 12235825 [Gene therapy for Parkinson's disease: studies in animal models]. 2001 Dec 2
130 10616810 A new radiopharmaceutical for the cerebral dopaminergic presynaptic function: 6-radioiodinated L-meta-tyrosine. 2000 Jan 1
131 10877910 Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. 2000 Jul 3
132 10889538 Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. 2000 May 2
133 10900396 Entacapone and selegiline with L-dopa in patients with Parkinson's disease: an interaction study. 2000 Oct 1 1
134 10945765 Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. 2000 Jul 20 3
135 11128607 Gene therapy of Parkinson's disease using adeno-associated virus (AAV) vectors. 2000 2
136 11144954 The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models. 2000 Sep-Oct 3
137 9893421 High presynaptic dopaminergic activity in children with Tourette's disorder. 1999 Jan 2
138 10343328 Upregulation of the aromatic amino acid decarboxylase under neonatal asphyxia. 1999 Apr 1
139 10450262 High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. 1999 Aug 1
140 10522874 Clinical and therapeutic observations in aromatic L-amino acid decarboxylase deficiency. 1999 Oct 12 1
141 10578236 Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. 1999 Nov 4
142 10821639 Tyrosine hydroxylase and aromatic L-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex. 1999 Jul 2 3
143 9535130 A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxylase and aromatic L-amino acid decarboxylase. 1998 Feb 27 1
144 9572873 Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label. 1998 May 5 2
145 9613721 Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies. 1998 1
146 9747462 In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. 1998 Jun 2
147 9084422 Intrastriatal grafting of Cos cells stably expressing human aromatic L-amino acid decarboxylase: neurochemical effects. 1997 Apr 5
148 9302099 Demonstration of L-dopa decarboxylating neurons specific to human striatum. 1997 Aug 29 2
149 9013415 An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa. 1996 2
150 7567987 Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. 1995 Sep 12 1